LED Medical Diagnostics Inc LEDIF

RE:Financials out and no surprise

[electricsockets]

bad financials and now this too to seriously consider:

"I am very excited about the oral cancer application because the competition is using twenty year old technology and there is already a billing code and reimbursement in the US for using any adjunctive device while screening for oral cancer. This means that a dentist can bill an extra $35 for using the device and we estimate that they can add about $20,000 to their annual revenue. This has driven sales of the devices that are currently on the market. There are only three competing devices that we know of and they are all relying on using one to three wavelengths to produce autofluorescence which causes all abnormal tissue to stand out. The problem with these old devices is that they are based on technology that was patented in the early nineties and is now in the public domain, so I anticipate many inexpensive imitators to start arriving on the market.

The other problem with them is that they are very simple with only one to three different wave lengths, no built in camera, and no diagnostic algorithm. In fact, studies have shown that fluorescent illumination by itself is associated with a high level of false positives which is a serious drawback for oral cancer screening. The reason some dentists, nevertheless, use the old style devices now is because they have no alternatives. We intend to dominate this market, and with 170,000 dentists in the United States alone, the total market is potentially worth a few hundred million.” ex Verisante CEO via new article on https://www.cantechletter.com

Read more at https://www.stockhouse.com/companies/bullboard/v.vrs/verisante-technology,-inc?postid=21926803#jAM1UUDltV9Qk1LA.99